Foxo Technologies Inc (FOXO)
$0.21
Performance
- $0.21$0.22$0.21
2.19%
Downside
Day's Volatility :4.51%
Upside
2.37%
- $0.21$3.28$0.21
0.0%
Downside
52 Weeks Volatility :93.6%
Upside
93.6%
Returns
| Period | Foxo Technologies Inc | Index (Russel 2000) |
|---|---|---|
3 Months | -23.58% | 0.0% |
6 Months | -22.92% | 0.0% |
1 Year | -84.56% | 0.0% |
3 Years | -97.79% | -20.2% |
Highlights
Market Capitalization | 2.5M |
Book Value | - $1.5 |
Earnings Per Share (EPS) | -4.02 |
Profit Margin | 0.0% |
Operating Margin TTM | -16842.86% |
Return On Assets TTM | -129.62% |
Return On Equity TTM | -1754.5% |
Revenue TTM | 139.0K |
Revenue Per Share TTM | 0.02 |
Quarterly Revenue Growth YOY | -46.2% |
Gross Profit TTM | 120.0K |
EBITDA | -12.7M |
Diluted Eps TTM | -4.02 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Analyst Recommendation
Technicals Summary
Sell
Neutral
Buy
Foxo Technologies Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Foxo Technologies Inc | -16.96% | -22.92% | -84.56% | -97.79% | -97.84% |
Solventum Corp | 13.4% | -16.71% | -16.71% | -16.71% | -16.71% |
 Veeva Systems Inc. | 1.24% | -10.63% | -7.18% | -43.19% | 9.43% |
 Ge Healthcare Technologies Inc. | 2.46% | 9.25% | 3.22% | 32.12% | 32.12% |
 Healthequity Inc | -3.68% | 3.76% | 26.99% | 6.89% | -2.18% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Foxo Technologies Inc | 0.0 | NA | NA | 0.0 | -17.55 | -1.3 | NA | -1.5 |
Solventum Corp | NA | NA | NA | 6.26 | 0.17 | 0.08 | NA | NA |
Veeva Systems Inc. | 54.35 | 54.35 | 1.35 | 4.76 | 0.13 | 0.06 | NA | 30.25 |
Ge Healthcare Technologies Inc. | 23.5 | 23.5 | 20.11 | 4.27 | 0.22 | 0.06 | 0.0 | 16.23 |
Healthequity Inc | 85.91 | 85.91 | 2.29 | 2.19 | 0.04 | 0.03 | NA | 24.11 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Foxo Technologies Inc | NA | $2.5M | -97.84% | 0.0 | 0.0% |
Solventum Corp | Hold | $10.8B | -16.71% | NA | 15.73% |
Veeva Systems Inc. | Buy | $29.8B | 9.43% | 54.35 | 22.34% |
Ge Healthcare Technologies Inc. | Buy | $36.9B | 32.12% | 23.5 | 8.05% |
Healthequity Inc | Buy | $6.9B | -2.18% | 85.91 | 7.71% |
Insights on Foxo Technologies Inc
Increasing Revenue
Revenue is up for the last 2 quarters, 10.0K → 169.0K (in $), with an average increase of 94.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -3.66M → -3.85M (in $), with an average decrease of 5.4% per quarter
Vs HQY
In the last 1 year, Healthequity Inc has given 27.0% return, outperforming this stock by 111.6%
Vs HQY
In the last 3 years, Healthequity Inc has given 6.9% return, outperforming this stock by 104.7%
Company Information
formerly yousurance and life epigenetics. foxo bioscience is transforming the global longevity insurance industry with a next-generation underwriting protocol and consumer engagement platform based on epigenetic technology and insights. we also offer leading supervised machine learning and artificial intelligence technologies to identify epigenetic biomarkers that measure current states of health and aging.
Organization | Foxo Technologies Inc |
Employees | 0 |
CEO | Mr. Mark Brian White |
Industry | Technology |
